Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MoU) with Qatar International Islamic Bank (QIIB) to explore collaborative pathways that will broaden access to services and create business development opportunities.
Sidra Medicine, a member of Qatar Foundation, will host its first Disease Modeling and Therapeutics (DMT) conference from 29 to 30 September 2025 in Doha, Qatar.
Sidra Medicine, a member of Qatar Foundation and Rady Children’s Institute for Genomic Medicine (RCIGM®) have signed an agreement to collaborate on implementing RCIGM’s genome-based newborn screening research program, BeginNGS (pronounced “beginnings”).
Sidra Medicine, a member of Qatar Foundation, offers a specialized eating disorders clinic within its Adolescent Medicine program to support children and young people, aged 8 to 17.
Sidra Medicine, a member of Qatar Foundation, has appointed Dr. Dina Schnurman as its new Chief Nursing Officer (CNO).
Sidra Medicine, a member of Qatar Foundation, has helped develop an artificial intelligence (AI) powered tool that predicts the risk of developing Type 1 Diabetes (T1D), enabling earlier diagnosis and more targeted care.
Sidra Medicine, a member of Qatar Foundation, will host its annual Women’s Health Conference (WHC 2025) from 26 to 27 September 2025 at the Sidra Medicine auditorium in Doha, Qatar.
Collaborative Study Findings Help Define New Disease Mechanism for Ritscher-Schinzel Syndrome 16 July 2025, Doha, Qatar –Sidra Medicine, a member of Qatar Foundation, has contributed to a groundbreaking study that
Sidra Medicine, a member of Qatar Foundation, has contributed to a major international research study published in Nature Metabolism, titled "Towards a consensus atlas of human and mouse adipose tissue at single cell resolution".
